| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01b2e86c1cb6aac7563a7367da0265b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3bb2478d0f04555a7bd1c187cc33a759
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e388911162aa60ca4fbf1d0dc2a6bca1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14bc1485fab2891f32e9e882b19f5e13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_678bfbbf2497bfefaedb5a0657d26ac9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24222 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-35 |
| filingDate |
2006-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8214b817107a79a8ee66c985d29511fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aededa9205f9de952198641139391af9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a80b1d147913106e5087ee97d7efd494
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e9fbc9bcaa98160ca3c8c08f25a145e |
| publicationDate |
2006-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006080340-A1 |
| titleOfInvention |
Concomitant use of hepatitis c virus-origin peptide with interferon |
| abstract |
It is intended to disclose a method of treating a patient suffering from an HCV-associated disease which comprises administering to a patient a combination of a hepatitis C virus-origin peptide, which contains an HLA-binding motif compatible with the HLA of the patient in the sequence thereof and is recognized by an antibody detected from patients having hepatitis C virus, with at least one member selected from interferon and liver protectors (preferably interferon). This method is a new therapy for chronic hepatitis which is applicable, in particular, to interferon and ribavirin insensitivities and post-therapeutic hepatocarcinogenesis. It is also intended to disclose a medicinal composition for treating a patient suffering from an HCV-associated disease which contains a hepatitis C virus-origin peptide, which contains an HLA-binding motif compatible with the HLA of the patient in the sequence thereof and is recognized by an antibody detected from patients having hepatitis C virus, and is to be used together with at least one member selected from interferon and liver protectors (preferably interferon). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014294942-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011001897-A1 |
| priorityDate |
2005-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |